Illumina Obtains More Than 55 Gb from GA; Expects Large NIH Stimulus Awards for Sequencing
July 28, 2009
Illumina Obtains More Than 55 Gb from GA; Expects Large NIH Stimulus Awards for Sequencing
The company reported $162 million in total revenue for the second quarter, a 15 percent increase over the prior-year quarter that company officials attributed to "significant" growth in sales of sequencing products.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Illumina Books Orders for More than 135 MiSeqs, Starts Early-Access Shipments
August 2, 2011 / In Sequence - Illumina Says 'Significant Growth' in Sequencing Demand Drove 12-Percent Rise in Q4 Revenue
February 9, 2010 / In Sequence - Defective Sequencing Reagents to Cost Illumina up to $23M in 2009; Company Says Problem is Solved
November 3, 2009 / In Sequence - Amid Declining Revenues, Illumina Plans to Restructure, Focus on Clinical Market
October 25, 2011 / In Sequence - Illumina CEO Predicts Routine Tumor Sequencing, Infant Genome Screening within Next Decade
June 15, 2011 / Clinical Sequencing News